- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/107 - Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Patent holdings for IPC class C07D 491/107
Total number of patents in this class: 2302
10-year publication summary
|
112
|
117
|
156
|
154
|
164
|
175
|
188
|
199
|
190
|
42
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10467 |
62 |
| Hoffmann-La Roche Inc. | 3646 |
49 |
| VALO Health, Inc. | 184 |
44 |
| Bristol-myers Squibb Company | 4817 |
39 |
| F. Hoffmann-La Roche AG | 7874 |
37 |
| Merck Sharp & Dohme LLC | 3726 |
36 |
| Takeda Pharmaceutical Company Limited | 2728 |
34 |
| Merck Patent GmbH | 5743 |
32 |
| Gilead Sciences, Inc. | 2161 |
30 |
| Vertex Pharmaceuticals Incorporated | 1607 |
28 |
| Kala bio, Inc. | 42 |
24 |
| Amgen Inc. | 4319 |
22 |
| Boehringer Ingelheim International GmbH | 4571 |
19 |
| Shionogi & Co., Ltd. | 833 |
19 |
| Genentech, Inc. | 4061 |
18 |
| AstraZeneca AB | 2823 |
17 |
| Bayer AG | 3418 |
17 |
| Bayer Pharma AG | 1034 |
17 |
| Pfizer Inc. | 3383 |
16 |
| Epizyme, Inc. | 366 |
16 |
| Other owners | 1726 |